Viatris (NASDAQ:VTRS) operates as a global healthcare company, dedicated to empowering people worldwide to live healthier at every stage of life. It specializes in producing and distributing a vast array of primary care medicines, including branded, generic, and over-the-counter products. Viatris focuses on making treatment more accessible and affordable, aiming to address some of the world's most pressing healthcare needs. The company's projects span across various therapeutic areas, including cardiovascular, infectious diseases, oncology, and diabetes, among others. Viatris aims to innovate to enhance patient care, with a commitment to sustainability and supporting communities to achieve better health outcomes.